Intranasal SPC-15 for PTSD (with Silo Pharma)
Post-Traumatic Stress Disorder
Preclinical/CMC DevelopmentActive
Key Facts
About Resyca
Resyca BV is a private, Netherlands-based company that has established itself as a specialist in innovative soft mist drug delivery platforms. Its core technologies, the PFSI™ (pre-filled syringe inhaler) and Pulmospray®/Ultra Soft Nasal Pump Spray systems, are designed to aerosolize liquid formulations—including sensitive biologics and high-dose drugs—for targeted lung and nasal cavity delivery. Operating as a B2B platform and development partner, Resyca collaborates with pharmaceutical companies to accelerate combination products to market, leveraging clinically validated, IP-protected devices that align with sustainability goals by avoiding propellants.
View full company profileTherapeutic Areas
Other Post-Traumatic Stress Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| PTSD Program | Ignite Biomedical | Discovery |
| PTSD Studies | Pacific Clinical Research Medical Group | Phase 2/3 |